Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
Title:
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
Author:
Ballard, Clive Banister, Carol Khan, Zunera Cummings, Jeffrey Demos, George Coate, Bruce Youakim, James M Owen, Randall Stankovic, Srdjan